Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
FranceStudy on the Effects of Metformin in Patients with Cirrhosis and Portal Hypertension Already Treated with Carvedilol
FranceStudy on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors
FranceStudy on A49, A52, and Litenimod Sodium for Patients with Glioblastoma
FranceStudy on Pravastatin for Patients with Severe Radio-Induced Breast Fibrosis After Breast Cancer
FranceStudy on Retinoblastoma Treatment Using Etoposide, Carboplatin, and Melphalan for Patients with Specific Eye Conditions
FranceLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
FranceStudy of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes
FranceStudy on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients
FranceStudy on the Effect of Hydroxychloroquine for Patients with IgA Nephropathy and High Albumin Levels
FranceStudy of personalized rituximab dosing using artificial intelligence in patients with membranous nephropathy
FranceStudy on How Metformin Affects Arterial Calcification in Patients with Type 1 Diabetes Without Chronic Kidney Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
